[HTML][HTML] Shikonin inhibits tumor growth of ESCC by suppressing PKM2 mediated aerobic glycolysis and STAT3 phosphorylation

Q Zhang, Q Liu, S Zheng, T Liu, L Yang, X Han… - Journal of …, 2021 - ncbi.nlm.nih.gov
Background: Shikonin, a small molecule inhibitor of pyruvate kinase 2 (PKM2), has been
demonstrated to play the antitumor effect in various cancers. However, the specific effects …

Shikonin inhibits tumor growth in mice by suppressing pyruvate kinase M2-mediated aerobic glycolysis

X Zhao, Y Zhu, J Hu, L Jiang, L Li, S Jia, K Zen - Scientific reports, 2018 - nature.com
Shift metabolism profile from mitochondrial oxidative phosphorylation to aerobic glycolysis
(Warburg effect) is a key for tumor cell growth and metastasis. Therefore, suppressing the …

Experimental study of hepatocellular carcinoma treatment by shikonin through regulating PKM2

T Liu, S Li, L Wu, Q Yu, J Li, J Feng… - Journal of …, 2020 - Taylor & Francis
Objective Shikonin is a natural product with many activities, including anti-cancer effects.
Pyruvate kinase type M2 (PKM2) plays a crucial role in the growth of tumor cells. However …

Shikonin differentially regulates glucose metabolism via PKM2 and HIF1α to overcome apoptosis in a refractory HCC cell line

W Yang, J Liu, L Hou, Q Chen, Y Liu - Life Sciences, 2021 - Elsevier
Aims In tumor cells, shikonin treatment has been reported to inhibit glycolysis by
suppressing the activity of pyruvate kinase M2 (PKM2) and to induce apoptosis by …

Shikonin and its analogs inhibit cancer cell glycolysis by targeting tumor pyruvate kinase-M2

J Chen, J Xie, Z Jiang, B Wang, Y Wang, X Hu - Oncogene, 2011 - nature.com
We recently reported that shikonin and its analogs were a class of necroptotic inducers that
could bypass cancer drug resistance. However, the molecular targets of shikonin are not …

Shikonin inhibited glycolysis and sensitized cisplatin treatment in non-small cell lung cancer cells via the exosomal pyruvate kinase M2 pathway

Y Dai, Y Liu, J Li, M Jin, H Yang, G Huang - Bioengineered, 2022 - Taylor & Francis
The active ingredient of the traditional Chinese medicine comfrey is shikonin, a
naphthoquinone compound. The focus of this study was to investigate the effect of shikonin …

[HTML][HTML] Efficacy of Shikonin against Esophageal Cancer Cells and its possible mechanisms in vitro and in vivo

JC Tang, J Zhao, F Long, J Chen, B Mu, Z Jiang… - Journal of …, 2018 - ncbi.nlm.nih.gov
Increasing evidences indicate that shikonin can suppress the tumor growth. However, the
mechanisms remain elusive. In the present study, we investigated the effects and …

Design, synthesis and biological evaluation of novel modified dual-target shikonin derivatives for colorectal cancer treatment

Y Ma, X Lai, Z Wen, Z Zhou, M Yang, Q Chen… - Bioorganic …, 2023 - Elsevier
Warburg effect provides energy and material essential for tumor proliferation, the reverse of
Warburg effect provides insights into the development of a novel anti-cancer strategy …

Antitumor effect of Shikonin, a PKM2 inhibitor, in cholangiocarcinoma cell lines

U Thonsri, W Seubwai, S Waraasawapati… - Anticancer …, 2020 - ar.iiarjournals.org
Background/Aim: Pyruvate kinase M2 (PKM2) is an enzyme that is predominantly
overexpressed in various types of cancer. The role of PKM2 in liver fluke-associated …

PKM2/PDK1 dual-targeted shikonin derivatives restore the sensitivity of EGFR-mutated NSCLC cells to gefitinib by remodeling glucose metabolism

H Lin, H Han, M Yang, Z Wen, Q Chen, Y Ma… - European Journal of …, 2023 - Elsevier
Abstract Pyruvate kinase 2 (PKM2) and pyruvate dehydrogenase kinase 1 (PDK1) are two
key enzymes in tumor glucose metabolism pathway that not only promote tumor growth and …